Noticias de Eulerpool Vir Biotechnology

Vir Biotechnology Noticias de Acciones

Vir Biotechnology es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Vir Biotechnology.

• 29 de mayo ·

  Yahoo
  Spero Therapeutics And 2 Other Promising Penny Stocks To Watch
• 9 de mayo ·

  Yahoo
  Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study
• 8 de mayo ·

  SeekingAlpha
  Vir Biotechnology: Tobevibart Combination Pushing Forward For Needed HDV Treatment
• 8 de mayo ·

  Yahoo
  Q1 2025 Vir Biotechnology Inc Earnings Call
• 8 de mayo ·

  Yahoo
  Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
• 24 de abril ·

  Yahoo
  Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025
• 9 de abril ·

  Yahoo
  Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple
• 30 de marzo ·

  SeekingAlpha
  abrdn Healthcare Investors Q4 2024 Commentary
• 28 de marzo ·

  Yahoo
  Vir Biotechnology, Inc. (NASDAQ:VIR) is favoured by institutional owners who hold 53% of the company
• 4 de marzo ·

  SeekingAlpha
  Vir Biotechnology: Catalysts Ahead In Hepatitis And Oncology